A phase 2 multicenter study of Iovance autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic NSCLC Meeting Abstract


Authors: Massarelli, E.; Schoenfeld, A.; Chesney, J.; Hong, Y.; Lammers, P.; Nieva, J.; Wise-Draper, T.; Goldberg, Z.; Cacovean, A.; Yadav, B.; Chen, G.; Jagasia, M.; Graf Finckenstein, F.; Fardis, M.; Sukari, A.
Abstract Title: A phase 2 multicenter study of Iovance autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic NSCLC
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: lung cancer; adoptive cell therapy; tumor-infiltrating lymphocytes; non-small cell
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S1012
Language: English
ACCESSION: WOS:000709606500334
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.334
Notes: Meeting Abstract: P14.04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors